For informational purposes only — not investment advice

← Back to signals

LRCX

LONGINSIDER SELLCONGRESS BUYCONGRESS SELL

Lam Research Corp

Research: Finviz ↗·Perplexity ↗

Funds
3
Score
3.34
vs SPY
-24.1%
Stock return (since Q-end)
-20.1%
SPY return (since Q-end)
+4.0%
Current price
$345.80
Days to cover (short int.)
3.1d↓-6.0%
as of 2026-09-15

News Summary

Positive

Lam Research delivered a strong earnings beat in Q4 2026 with EPS of $1.82 vs. $1.69 consensus and record revenue of $6.72B (up 30% YoY), driven by robust NAND demand, triggering a historic 20% single-day stock surge on July 30. However, valuation concerns have emerged with the stock trading at 62x forward P/E after a 120% seven-month run-up, and analysts flagged overextension despite continued bullish sentiment on growth fundamentals and U.S. manufacturing expansion in Boise.

Red flags

  • •Valuation stretched at 62x forward P/E after significant run-up
  • •Stock concentration risk: 120% gain in seven months creates elevated downside volatility exposure

Funds Buying (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Altimeter CapitalBrad Gerstner394K+394K$171M1.7%—NEW
Duquesne Family OfficeStanley Druckenmiller44K+44K$19M0.4%—NEW
Maverick CapitalLee Ainslie4K+4K$2M<0.1%—NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where LRCX ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Altimeter Capital

position #16 of this fund's book

  1. 13MICRON TECHNOLOGY INC$242M
  2. 14APPLIED MATLS INC$189M
  3. 15KLA CORP$174M
  4. 16LAM RESEARCH CORP$171M
  5. 17ROBINHOOD MKTS INC$90M
  6. 18ALPHABET INC$63M
  7. 19SYNOPSYS INC$63M

Values are quarter-end position sizes. Shown only for funds where LRCX ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Signal History

QuarterDirectionFundsScorevs SPY
Q2 2026LONG33.34-24.1%
Q1 2026LONG33.39+36.0%

Same issuer appearing in consecutive quarters — persistent institutional conviction. Returns are frozen at each archived quarter's last refresh.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
ARCHER TIMOTHYPresident and CEOSELL30K$319.26$9.58M2026-09-09↗
Mayer Bethany—SELL10K$314.74$3.01M2026-09-09↗
Varadarajan SeshasayeeSenior Vice PresidentSELL20K$291.32$5.83M2026-09-02↗
Varadarajan SeshasayeeSenior Vice PresidentSELL12K$291.32$3.57M2026-09-02↗
Varadarajan SeshasayeeSenior Vice PresidentSELL27K$291.32$8.01M2026-09-02↗
Harter AvaChief Legal OfficerSELL5K$302.46$1.51M2026-08-31↗
ARCHER TIMOTHYPresident and CEOSELL30K$300.00$9.00M2026-08-06↗
TALWALKAR ABHIJIT Y—SELL18K$335.00$6.12M2026-07-13↗
ARCHER TIMOTHYPresident and CEOSELL30K$390.01$11.70M2026-07-02↗

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
Vanguard Capital ManagementSC 13G93.6M7.5%2026-04-30↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.

Congressional Trading

MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Sheldon Whitehousesenate—SELL$1,001 - $15,0002026-08-132026-09-02↗
Alan Armstrongsenate—BUY$1,001 - $15,0002026-03-272026-07-21↗

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.